
|Articles|December 1, 1998
Supplements and Featured Publications
- New Developments in the Treatment of Hypertension: What the HOT Study Means to JNC-VI
- Volume 4
- Issue 13 Suppl
Introduction
Author(s)Gary Gerstenblith, MD, Steven Schulman, MD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Hypertension in the Older Patientabout 27 years ago
Barriers to Guideline Adherenceabout 27 years ago
Hypertension in Managed Careabout 27 years ago
Beta Blockers as First-Line Therapy for Hypertension in the Elderlyabout 27 years ago
Cost Effectiveness of Intensive Treatment of Hypertensionabout 27 years ago
Selected Abstractsabout 27 years ago
CME Quizabout 27 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
Making the Genetic Models Match the Ancestry of Patient Populations
3
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5














































